Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

二维码有效期 120s

作者 Zeng Yan-Ming ^[1] Xu Xiao-Lei ^[1] He Xiao-Qing ^[1] Tang Sheng-Quan ^[1] Li Yao ^[1] Huang Yin-Qiu ^[2] Harypursat Vijay ^[1] Chen Yao-Kai ^[3] 学术成果认领

作者单位 Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing 400036, China ^[1] National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing 400036, China ^[2] Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing 400036, China; National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing 400036, China ^[3]

主题词利巴韦林(Ribavirin)干扰素α(Interferon-alpha)安全(Safety)病人(Patients)冠状病毒属(Coronavirus)

栏目名称 Correspondence

DOI 10.1097/CM9.0000000000000790

发布时间 2025-02-25

基金项目

This work was supported by the Chongqing Special Research Project for Prevention and Control of Novel Coronavirus Pneumonia This work was supported by the Chongqing Special Research Project for Prevention and Control of Novel Coronavirus Pneumonia

浏览103
被引1
下载8

中华医学杂志英文版

2020年133卷9期

1132-1134页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

检索历史清除